v3.26.1
Note 2 - Summary of Significant Accounting Policies and Basis of Presentation (Details Textual)
12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Working Capital $ 7,800,000  
Retained Earnings (Accumulated Deficit), Total 184,137,952 $ 164,273,050
Cash 14,400,000  
Net Income (Loss) Attributable to Parent, Total (19,864,902) (29,918,802)
Cash, Uninsured Amount 878,844 937,004
Proceeds from Short-Term Debt 406,875 976,904
Financing for Liability Insurance Policy Premiums [Member]    
Debt Instrument, Face Amount 406,875 458,154
Proceeds from Short-Term Debt $ 325,500 $ 366,523
Debt Instrument, Interest Rate, Stated Percentage 7.15% 7.90%
Debt Instrument, Term 10 months 10 months
Supplier Concentration Risk [Member] | Research and Development Costs [Member]    
Number of Vendors 1 2
Supplier Concentration Risk [Member] | Research and Development Costs [Member] | Vendor One [Member]    
Concentration Risk, Percentage 39.00% 40.00%
Supplier Concentration Risk [Member] | Research and Development Costs [Member] | Vendor Two [Member]    
Concentration Risk, Percentage   14.00%